Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis.

Literature DB >> 10606618

Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis.

H L Weiner¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1999 PMID： 10606618 PMCID： PMC409889 DOI： 10.1172/JCI8775

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

17 in total

Review 1. Oral tolerance: mechanisms and therapeutic applications.

Authors: A M Faria; H L Weiner
Journal: Adv Immunol Date: 1999 Impact factor: 3.543

2. Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis.

Authors: F Baggi; F Andreetta; E Caspani; M Milani; R Longhi; R Mantegazza; F Cornelio; C Antozzi
Journal: J Clin Invest Date: 1999-11 Impact factor: 14.808

Review 3. Myasthenia gravis.

Authors: D B Drachman
Journal: N Engl J Med Date: 1994-06-23 Impact factor: 91.245

4. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.

Authors: Z Y Wang; J Qiao; H Link
Journal: J Neuroimmunol Date: 1993-05 Impact factor: 3.478

5. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

Authors: C C Whitacre; I E Gienapp; C G Orosz; D M Bitar
Journal: J Immunol Date: 1991-10-01 Impact factor: 5.422

6. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

Authors: S H Im; D Barchan; S Fuchs; M C Souroujon
Journal: J Clin Invest Date: 1999-12 Impact factor: 14.808

7. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.

Authors: K V Toyka; D B Drachman; D E Griffin; A Pestronk; J A Winkelstein; K H Fishbeck; I Kao
Journal: N Engl J Med Date: 1977-01-20 Impact factor: 91.245

8. Transforming growth factor-beta 1 is a costimulator for IgA production.

Authors: P H Kim; M F Kagnoff
Journal: J Immunol Date: 1990-05-01 Impact factor: 5.422

9. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.

Authors: A Miller; O Lider; O Abramsky; H L Weiner
Journal: Eur J Immunol Date: 1994-05 Impact factor: 5.532